<DOC>
	<DOCNO>NCT00350350</DOCNO>
	<brief_summary>The primary objective trial evaluate efficacy , safety clinical acceptability OGT oromucosal spray relief symptom sign xerostomia comparison saliva substitute ( European Medical Device ) .</brief_summary>
	<brief_title>OGT Spray Management Xerostomia Elderly</brief_title>
	<detailed_description>Xerostomia excessive dryness mouth . It due insufficient ( hyposialism ) inexistent ( asialia ) saliva secretion . There many cause . Transitory xerostomia may occur presence anxiety ( stage fright , fear dehydration ) . Prolonged xerostomia often related systemic disease , certain medicine radiotherapy head neck . Xerostomia often accompany buccal symptom sign impair sense taste , fetid breath mouth ulcer , disturbs function speech , chew swallowing . Because reduced salivary secretion , disturbance microbial colonization buccal cavity , increase demineralization decrease remineralization teeth , impaired retention denture , dehydration mucosa reduce lubrication buccal mucosa . These complication may take form dental caries , candidiasis , atrophy feeling burn mucosa , difficulty retain denture , impaired speech swallow impression decrease impaired sense taste . Xerostomia significant harmful effect buccal cavity quality life patient . Xerostomia prevalence rate order 18-61 % report elderly . These rate generally high woman men increase age . They also higher population institution take multiple medication . Wearing denture , stress psychological factor also suggest factor increase risk worsen xerostomia . Treatments xerostomia saliva substitute saliva stimulant . OGT Spray neither substitute stimulant saliva . OGT Spray solution oromucosal spray lubricant protective action . The aim study demonstrate OGT Spray ( oral lubricant ) effective subjective relief dry mouth symptom objective sign dry mouth elderly .</detailed_description>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>male female , institutionalize least 70 year age diagnosis xerostomia confirm objectively saliva absorption test stop palliative treatment xerostomia legally capable give consent capable agree participate study capable accept answer study questionnaires accordance term French Huriet Act clinical trial , remain establishment throughout study period Concomitant treatment incompatible trial , especially alcoholic solution buccal fungal infection systemic infection current dental care current participation clinical trial allergy know intolerance one constituents trial product treatment atropine presence active lifethreatening disease</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>XEROSTOMIA</keyword>
	<keyword>MOUTH DRYNESS</keyword>
	<keyword>ELDERLY</keyword>
	<keyword>ORAL LUBRICANT</keyword>
</DOC>